SB 675
Requiring participant in federal 340B Drug Pricing Program to report certain data
Take action
Record your position on this measure.
Sign in to record your position, submit testimony, or contact your legislator.
Sign in to take action- Introduced
- Passed Senate
- Passed House of Delegates
- To Governor
- Became Law
Bill overview
This bill requires pharmacies participating in the federal 340B Drug Pricing Program in West Virginia to report specific data to the Board of Pharmacy. These reports will include details about drug acquisition costs, payments received and made, the number of claims, and how savings from the program are used for charity care and community benefits. The Board of Pharmacy will then compile and analyze this data, posting an annual report on its website for review by legislative committees.
Key provisions
- Pharmacies participating in the 340B Drug Pricing Program must report annually.
- Reports must include the name of the pharmacy and aggregate acquisition and payment costs.
- Data must be broken down by payer type (Commercial, Medicaid, Medicare).
- The number of claims for prescription drugs must be reported.
- Pharmacies must detail how 340B savings are used for charity care or similar programs.
- The West Virginia Board of Pharmacy will compile and analyze the data.
- The Board will post an annual report on its website.
- The data submitted is confidential and not publicly available.
Who is affected
- Pharmacies participating in the 340B Drug Pricing Program
- Patients receiving discounted medications through the 340B program
- The West Virginia Board of Pharmacy
- The Joint Committee of Government and Finance
- The Joint Standing Committee on Insurance and PEIA
Notable changes
Arguments in favor
Reasons to support this legislation.
No arguments in favor have been submitted.
Submit yoursArguments opposed
Reasons to oppose this legislation.
No arguments opposed have been submitted.
Submit yours